What's sending this ASX 300 share 10% higher today?

Shareholders of this company will be smiling on Friday.

| More on:
A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The APM Human Services International Ltd (ASX: APM) share price is ending the week in style.

In morning trade, the ASX 300 share is up almost 11% to $2.06.

Why is this ASX 300 share rocketing higher?

Investors have been scrambling to buy this human services provider's shares today after it announced a major contract win in the UK.

According to the release, APM has been confirmed as the successful bidder to deliver Functional Assessment Services (FAS) on behalf of the Department for Work and Pensions (DWP) in the London, South-East, and East Anglia region.

The release notes that these services provide an assessment of the functional impact of disability and illness on an individual's daily life and their needs as a result of their health conditions.

The contract is for an initial five-year period and has a total value of $720 million or 384 million pounds. It is expected to commence in 2024 and includes an option for a two-year extension.

It is worth noting that this revenue won't all flow through to the bottom line, though. The company will require an investment in capital expenditure and working capital in FY 2023 and FY 2024 before the contract commences.

Speaking of profits, the ASX 300 share has also provided the market with an update on its performance and guidance for FY 2023.

Trading update

Pleasingly, APM continues to make positive progress in executing its strategy. It also continues to increase its average tenure across key programs through new contract awards, retenders, and extensions. This has seen the base tenure (excluding future options) being more than 3 years across its largest contracts.

As for its guidance, the company is expecting its FY 2023 underlying net profit after tax and before amortisation (NPATA) to be in the range of $175 million and $180 million.

This will be up from $166.3 million despite the impacts of lower client flow into Employment Services Programs, a shortage of qualified allied health professionals, and higher interest costs.

Commenting on the contract award, APM Group's CEO, Michael Anghie, said:

We look forward to partnering with the Department of Work and Pensions to deliver these important Functional Assessment Services. APM is one of the leading health service providers in Australia delivering Assessment Services across a wide range of sectors including Health, Disability and Aged Care.

The opportunity to deliver Functional Assessment Services demonstrates the strength of our local service delivery team, our reputation for service excellence, and our ability to leverage APM's expertise across regions and markets. The contract win continues the trend of APM executing its strategy and diversifying its business globally both geographically and in terms of service and revenue models.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended APM Human Services International. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

Shot of a senior scientist looking stressed out while working in a lab.
Healthcare Shares

After soaring 40% in 2 weeks, this ASX All Ords healthcare stock has been downgraded

Here’s what analysts at Macquarie rate the stock as now.

Read more »

A little boy, soon to be a brother, kisses and holds his mum's pregnant tummy.
Healthcare Shares

Own NIB shares? Here are the key dates for 2026

NIB has released its corporate calendar, including dividend dates, for 2026.

Read more »

A male doctor wearing a white lab coat shrugs his shoulders and holds his hands up in the air looking confused
Healthcare Shares

ASX healthcare stock debuts at a massive discount to its initial public offer price

Saluda Medical shares have had a difficult start to public life, trading well below the initial public offer price.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Healthcare Shares

Why CSL shares now look 'massively oversold'

A leading investment expert says ASX investors have a rare chance to buy CSL shares at a discount.

Read more »

Scientists working in the laboratory and examining results.
Healthcare Shares

Which junior biotech's shares are flying on positive trial news?

This company's shares have surged higher after positive clinical trial results for its stroke treatment drug.

Read more »

Excited elderly woman on a swing.
Healthcare Shares

Guess which ASX 300 healthcare share is lifting off on $25 million news

The ASX 300 healthcare share is grabbing investor interest on Thursday. Let’s see why.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Doomed takeover bid for Mayne Pharma to come to an end

The Mayne Pharma takeover saga appears to be finally drawing to an end, with shareholders bearing the pain of the…

Read more »